88524-4 |
IRF-PAI v2.0 - Cognitive patterns - admission |
- |
^Patient |
RptPeriod |
- |
CMS Assessment |
|
ACTIVE |
IRF-PAI v2.0 - Cognitive patterns - admission during assessment period [CMS Assessment] |
|
MAJ |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
PANEL.SURVEY.CMS |
|
88524-4 |
|
CMS Assessment |
|
|
Subset |
|
|
|
0 |
|
|
|
|
|
|
Centers for Medicare and Medicaid Assessment; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Report period; Survey |
2.77 |
2.64 |
|
Organizer |
|
|
|
|
|
|
|
|
Release 2.77: TIME_ASPCT: Decision by CMS to update the Timing to RptPeriod from Pt for all CMS Assessments; Release 2.69: COMPONENT: Updated to only include IRF-PAI v2.0 in the name since active and future versions have been updated with the new reporting period terms and therefore have different children.; Previous Releases: This panel is in versions 2.0 and 3.0, so "v3.0" was added to the Component. |
0 |
88525-1 |
IRF-PAI v2.0 - Quality indicators - discharge |
- |
^Patient |
RptPeriod |
- |
CMS Assessment |
|
ACTIVE |
IRF-PAI v2.0 - Quality indicators - discharge during assessment period [CMS Assessment] |
|
MAJ |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
PANEL.SURVEY.CMS |
|
88525-1 |
|
CMS Assessment |
|
|
Subset |
|
|
|
0 |
|
|
|
|
|
|
Centers for Medicare and Medicaid Assessment; Disch; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Report period; Survey |
2.77 |
2.64 |
|
Organizer |
|
|
|
|
|
|
|
|
Release 2.77: TIME_ASPCT: Decision by CMS to update the Timing to RptPeriod from Pt for all CMS Assessments; |
0 |
88526-9 |
Guidance for percutaneous biopsy |
Find |
Chest>Lung.right |
Pt |
Doc |
CT |
|
ACTIVE |
CT Guidance for biopsy of Lung - right |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
RAD |
|
88526-9 |
|
CT |
|
|
Both |
|
|
|
0 |
CT Guided Lung-R Bx |
|
|
|
|
|
Bx; CAT scan; Computed tomography; Computerized tomography; CT guided pulmonary biopsy; CT scan; Document; Finding; Findings; Guid; Guide; Guided; Imaging; Lung; Lung-R; Perc; Point in time; Pulmonary; Pulmonology; R; Rad; RADIOLOGY; Random; Respiratory; RT; Thorax |
2.64 |
2.64 |
|
|
|
|
|
|
|
|
|
|
|
0 |
88527-7 |
Respiratory syncytial virus |
PrThr |
Cornea/Conjunctiva |
Pt |
Ord |
Organism specific culture |
|
ACTIVE |
Respiratory syncytial virus [Presence] in Cornea or Conjunctiva by Organism specific culture |
|
NAM |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
88527-7 |
|
Organism specific culture |
|
|
Both |
|
|
|
0 |
RSV Corn/Cnjt Ql Cult |
|
|
|
|
|
C&S; Corn/Cnjt; Corneal; Cult; Cultures; HRSV; ID; Infectious Disease; InfectiousDisease; Microbiology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; RSV; Screen; Spec |
2.72 |
2.64 |
|
|
|
|
|
|
|
|
|
|
Release 2.72: COMPONENT: Removed "identified" from the Component to align with the LOINC model for ordinal terms; |
0 |
88528-5 |
Respiratory syncytial virus RNA |
PrThr |
Cornea/Conjunctiva |
Pt |
Ord |
Probe.amp.tar |
|
ACTIVE |
Respiratory syncytial virus RNA [Presence] in Cornea or Conjunctiva by NAA with probe detection |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
88528-5 |
|
Probe.amp.tar |
|
|
Both |
|
|
|
0 |
RSV RNA Corn/Cnjt Ql NAA+probe |
|
|
|
|
|
3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Corn/Cnjt; Corneal; DNA NUCLEIC ACID PROBE; DNA probe; HRSV; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Ribonucleic acid; RSV; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification |
2.64 |
2.64 |
|
|
|
|
|
|
|
|
|
|
|
0 |
88529-3 |
Parainfluenza virus RNA |
PrThr |
Cornea/Conjunctiva |
Pt |
Ord |
Probe.amp.tar |
|
ACTIVE |
Parainfluenza virus RNA [Presence] in Cornea or Conjunctiva by NAA with probe detection |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
88529-3 |
|
Probe.amp.tar |
|
|
Both |
|
|
|
0 |
HPIV RNA Corn/Cnjt Ql NAA+probe |
|
|
|
|
|
3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Corn/Cnjt; Corneal; DNA NUCLEIC ACID PROBE; DNA probe; HPIV; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; Para; Parainflu; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Ribonucleic acid; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification |
2.64 |
2.64 |
|
|
|
|
|
|
|
|
|
|
|
0 |
8853-4 |
Oxygen saturation |
MFr |
Pulmonary artery.right |
Pt |
Qn |
|
|
ACTIVE |
Right pulmonary artery Oxygen saturation |
|
MIN |
DefinitionDescription |
|
|
% |
|
|
|
|
|
|
HEMODYN.MOLEC |
|
8853-4 |
|
|
|
|
|
|
|
|
0 |
SaO2 % PA-R |
|
|
|
|
|
Art; Cardio; Cardiology; Heart Disease; Hemodynamics; HEMODYNAMICS.MOLEC; Lung; Mass Fraction; O2; PA; PA-R; Percent; Point in time; Pulmonary; Pulmonology; QNT; Quan; Quant; Quantitative; R; Random; Respiratory; RT; SaO2; SAT; Satn; SO2; tO2 |
2.54 |
1.0h(3) |
|
|
|
|
|
|
|
% |
|
|
|
0 |
88530-1 |
Parainfluenza virus 4 RNA |
PrThr |
Cornea/Conjunctiva |
Pt |
Ord |
Probe.amp.tar |
|
ACTIVE |
Parainfluenza virus 4 RNA [Presence] in Cornea or Conjunctiva by NAA with probe detection |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
88530-1 |
|
Probe.amp.tar |
|
|
Both |
|
|
|
0 |
HPIV4 RNA Corn/Cnjt Ql NAA+probe |
|
|
|
|
|
3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Corn/Cnjt; Corneal; DNA NUCLEIC ACID PROBE; DNA probe; HPIV; HPIV4; Human rubulavirus 4; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; Para; Parainflu; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Ribonucleic acid; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification |
2.64 |
2.64 |
|
|
|
|
|
|
|
|
|
|
|
0 |
88531-9 |
Parainfluenza virus |
Prid |
Cornea/Conjunctiva |
Pt |
Nom |
Organism specific culture |
|
ACTIVE |
Parainfluenza virus identified in Cornea or Conjunctiva by Organism specific culture |
|
NAM |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
88531-9 |
|
Organism specific culture |
|
|
Observation |
|
|
|
0 |
HPIV Corn/Cnjt Cult |
|
|
|
|
|
C&S; Corn/Cnjt; Corneal; Cult; Cultures; HPIV; ID; Identity or presence; Infectious Disease; InfectiousDisease; Microbiology; Nominal; Para; Parainflu; Point in time; Random; Spec |
2.79 |
2.64 |
|
|
|
|
|
|
|
|
|
|
Release 2.79: COMPONENT: Triggered by the coll w SCT:The understanding is that the word "identified" refers to the property "PRID", its presence in the component is redundant to the property. Therefore it is better to remove "identified" from the component.; |
0 |
88532-7 |
Human metapneumovirus |
Prid |
Cornea/Conjunctiva |
Pt |
Nom |
Organism specific culture |
|
ACTIVE |
Human metapneumovirus identified in Cornea or Conjunctiva by Organism specific culture |
|
NAM |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
88532-7 |
|
Organism specific culture |
|
|
Observation |
|
|
|
0 |
hMPV Corn/Cnjt Cult |
|
|
|
|
|
C&S; Corn/Cnjt; Corneal; Cult; Cultures; hMPV; ID; Identity or presence; Infectious Disease; InfectiousDisease; Microbiology; Nominal; Point in time; Random; Spec |
2.79 |
2.64 |
|
|
|
|
|
|
|
|
|
|
Release 2.79: COMPONENT: Triggered by the coll w SCT:The understanding is that the word "identified" refers to the property "PRID", its presence in the component is redundant to the property. Therefore it is better to remove "identified" from the component.; |
0 |
88533-5 |
Adenovirus DNA |
PrThr |
Cornea/Conjunctiva |
Pt |
Ord |
Probe.amp.tar |
|
ACTIVE |
Adenovirus DNA [Presence] in Cornea or Conjunctiva by NAA with probe detection |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
88533-5 |
|
Probe.amp.tar |
|
|
Both |
|
|
|
0 |
HAdV DNA Corn/Cnjt Ql NAA+probe |
|
|
|
|
|
3 Self-Sustaining Sequence Replication; 3SR SR; Adeno virus; Amplif; Amplification; Amplified; Corn/Cnjt; Corneal; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; HAdV; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification |
2.64 |
2.64 |
|
|
|
|
|
|
|
|
|
|
|
0 |
88534-3 |
Human metapneumovirus RNA |
PrThr |
Cornea/Conjunctiva |
Pt |
Ord |
Probe.amp.tar |
|
ACTIVE |
Human metapneumovirus RNA [Presence] in Cornea or Conjunctiva by NAA with probe detection |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
88534-3 |
|
Probe.amp.tar |
|
|
Both |
|
|
|
0 |
hMPV RNA Corn/Cnjt Ql NAA+probe |
|
|
|
|
|
3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Corn/Cnjt; Corneal; DNA NUCLEIC ACID PROBE; DNA probe; hMPV; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Ribonucleic acid; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification |
2.64 |
2.64 |
|
|
|
|
|
|
|
|
|
|
|
0 |
88535-0 |
Cytomegalovirus DNA |
PrThr |
Bld.dot |
Pt |
Ord |
Probe.amp.tar |
|
ACTIVE |
Cytomegalovirus DNA [Presence] in DBS by NAA with probe detection |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
88535-0 |
|
Probe.amp.tar |
|
|
Both |
|
|
|
0 |
CMV DNA DBS Ql NAA+probe |
|
|
|
|
|
3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Blood; CMV; Cytomegalo virus; Cytomgal; DBS; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; Dried blood spot; Filter paper; FP; HHV-5; Human Herpesvirus-5; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification; WB; Whole blood |
2.64 |
2.64 |
|
|
|
|
|
|
|
|
|
|
|
0 |
88536-8 |
Varicella zoster virus DNA |
PrThr |
Asp |
Pt |
Ord |
Probe.amp.tar |
|
ACTIVE |
Varicella zoster virus DNA [Presence] in Aspirate by NAA with probe detection |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
88536-8 |
|
Probe.amp.tar |
|
|
Both |
|
|
|
0 |
VZV DNA Aspirate Ql NAA+probe |
|
|
|
|
|
3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Aspirate; Chicken pox; Chicken pox virus; Chickenpox; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; Herpes zoster; HHV-3; Human herpesvirus 3; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Shingles; Strand Displacement Amplification; TMA; Transcription mediated amplification; VZ; VZV; Zoster |
2.64 |
2.64 |
|
|
|
|
|
|
|
|
|
|
|
0 |
88537-6 |
Enterovirus |
Prid |
Pericard fld |
Pt |
Nom |
Organism specific culture |
|
ACTIVE |
Enterovirus identified in Pericardial fluid by Organism specific culture |
|
NAM |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
88537-6 |
|
Organism specific culture |
|
|
Both |
|
|
|
0 |
EV Pcar Cult |
|
|
|
|
|
C&S; Cardio; Cardiology; Cult; Cultures; Entero virus; EV; Heart Disease; ID; Identity or presence; Infectious Disease; InfectiousDisease; Microbiology; Nominal; PCAR; Pericardial Fluid; Point in time; Random; Spec |
2.79 |
2.64 |
|
|
|
|
|
|
|
|
|
|
Release 2.79: COMPONENT: Triggered by the coll w SCT:The understanding is that the word "identified" refers to the property "PRID", its presence in the component is redundant to the property. Therefore it is better to remove "identified" from the component.; |
0 |
88538-4 |
Enterovirus RNA |
PrThr |
Pericard fld |
Pt |
Ord |
Probe.amp.tar |
|
ACTIVE |
Enterovirus RNA [Presence] in Pericardial fluid by NAA with probe detection |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
88538-4 |
|
Probe.amp.tar |
|
|
Both |
|
|
|
0 |
EV RNA Pcar Ql NAA+probe |
|
|
|
|
|
3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Cardio; Cardiology; DNA NUCLEIC ACID PROBE; DNA probe; Entero virus; EV; EV-PCR; Heart Disease; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; Pcar; PCR; Pericardial fluid; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Ribonucleic acid; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification |
2.64 |
2.64 |
|
|
|
|
|
|
|
|
|
|
|
0 |
88539-2 |
Adenovirus DNA |
PrThr |
Stool |
Pt |
Ord |
Probe.amp.tar |
|
ACTIVE |
Adenovirus DNA [Presence] in Stool by NAA with probe detection |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
88539-2 |
|
Probe.amp.tar |
|
|
Both |
|
|
|
0 |
HAdV DNA Stl Ql NAA+probe |
|
|
|
|
|
3 Self-Sustaining Sequence Replication; 3SR SR; Adeno virus; Amplif; Amplification; Amplified; Bowel movement; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; Faecal; Faeces; Fecal; Feces; HAdV; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Stl; Stool = Fecal; Strand Displacement Amplification; TMA; Transcription mediated amplification |
2.64 |
2.64 |
|
|
|
|
|
|
|
|
|
|
|
0 |
8854-2 |
Oxygen saturation |
MFr |
Pulmonary wedge |
Pt |
Qn |
|
|
ACTIVE |
Pulmonary wedge Oxygen saturation |
|
MIN |
DefinitionDescription |
|
|
% |
|
|
|
|
|
|
HEMODYN.MOLEC |
|
8854-2 |
|
|
|
|
|
|
|
|
0 |
SaO2 % PW |
|
|
|
|
|
Hemodynamics; HEMODYNAMICS.MOLEC; Lung; Mass fraction; O2; Percent; Point in time; Pulmonary; Pulmonology; PW; QNT; Quan; Quant; Quantitative; Random; Respiratory; SaO2; SAT; Satn; SO2; tO2 |
2.4 |
1.0h(3) |
|
|
|
|
|
|
|
% |
|
|
|
0 |
88540-0 |
Enterovirus RNA |
PrThr |
Asp |
Pt |
Ord |
Probe.amp.tar |
|
ACTIVE |
Enterovirus RNA [Presence] in Aspirate by NAA with probe detection |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
88540-0 |
|
Probe.amp.tar |
|
|
Both |
|
|
|
0 |
EV RNA Aspirate Ql NAA+probe |
|
|
|
|
|
3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Aspirate; DNA NUCLEIC ACID PROBE; DNA probe; Entero virus; EV; EV-PCR; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Ribonucleic acid; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification |
2.64 |
2.64 |
|
|
|
|
|
|
|
|
|
|
|
0 |
88541-8 |
Adenovirus DNA |
PrThr |
Asp |
Pt |
Ord |
Probe.amp.tar |
|
ACTIVE |
Adenovirus DNA [Presence] in Aspirate by NAA with probe detection |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
88541-8 |
|
Probe.amp.tar |
|
|
Both |
|
|
|
0 |
HAdV DNA Aspirate Ql NAA+probe |
|
|
|
|
|
3 Self-Sustaining Sequence Replication; 3SR SR; Adeno virus; Amplif; Amplification; Amplified; Aspirate; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; HAdV; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification |
2.64 |
2.64 |
|
|
|
|
|
|
|
|
|
|
|
0 |
88542-6 |
HIV 1 RNA integrase gene mutations detected |
Prid |
CSF |
Pt |
Nom |
Sequencing |
|
ACTIVE |
HIV 1 RNA integrase gene mutations detected [Identifier] in Cerebral spinal fluid by Sequencing |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
ABXBACT |
|
88542-6 |
|
Sequencing |
|
|
Both |
|
|
|
0 |
HIV 1 RNA IN Mut Det CSF Seq |
|
|
|
|
|
AIDS; ANTIBIOTIC SUSCEPTIBILITIES; Cerebral spinal fluid; Cerebrospinal Fl; high-throughput sequencing; HIV 1 RNA IN gene mut det; HIV type 1; HIV type I; HIV1; HTS; Human immunodeficiency virus; i; ID; Identity or presence; Infectious Disease; InfectiousDisease; Mut; Mut Det; Mutation; Muts; Neuro; Neurology; Next generation sequencing; NGS; Nominal; Point in time; Random; Ribonucleic acid; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid |
2.64 |
2.64 |
|
|
|
|
|
|
|
|
|
|
|
0 |
88543-4 |
HIV 1 RNA protease gene mutations detected |
Prid |
CSF |
Pt |
Nom |
Sequencing |
|
ACTIVE |
HIV 1 RNA protease gene mutations detected [Identifier] in Cerebral spinal fluid by Sequencing |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
ABXBACT |
|
88543-4 |
|
Sequencing |
|
|
Both |
|
|
|
0 |
HIV 1 RNA PR Mut Det CSF Seq |
|
|
|
|
|
AIDS; ANTIBIOTIC SUSCEPTIBILITIES; Cerebral spinal fluid; Cerebrospinal Fl; high-throughput sequencing; HIV 1 RNA PR gene mut; HIV type 1; HIV type I; HIV1; HTS; Human immunodeficiency virus; i; ID; Identity or presence; Infectious Disease; InfectiousDisease; Mut; Mut Det; Mutation; Muts; Neuro; Neurology; Next generation sequencing; NGS; Nominal; Point in time; PR; Random; Ribonucleic acid; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid |
2.64 |
2.64 |
|
|
|
|
|
|
|
|
|
|
|
0 |
88544-2 |
HIV 1 RNA reverse transcriptase gene mutations detected |
Prid |
CSF |
Pt |
Nom |
Sequencing |
|
ACTIVE |
HIV 1 RNA reverse transcriptase gene mutations detected [Identifier] in Cerebral spinal fluid by Sequencing |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
ABXBACT |
|
88544-2 |
|
Sequencing |
|
|
Both |
|
|
|
0 |
HIV 1 RNA RT Mut Det CSF Seq |
|
|
|
|
|
AIDS; ANTIBIOTIC SUSCEPTIBILITIES; Cerebral spinal fluid; Cerebrospinal Fl; high-throughput sequencing; HIV 1 RNA RT; HIV 1 RNA RT gene mut; HIV type 1; HIV type I; HIV1; HTS; Human immunodeficiency virus; i; ID; Identity or presence; Infectious Disease; InfectiousDisease; Mut; Mut Det; Mutation; Muts; Neuro; Neurology; Next generation sequencing; NGS; Nominal; Point in time; Random; REV; Ribonucleic acid; RT; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid |
2.64 |
2.64 |
|
|
|
|
|
|
|
|
|
|
|
0 |
88545-9 |
Cytomegalovirus DNA |
NCnc |
Bld.dot |
Pt |
Qn |
Probe.amp.tar |
|
ACTIVE |
Cytomegalovirus DNA [#/volume] (viral load) in DBS by NAA with probe detection |
|
ADD |
DefinitionDescription |
|
|
copies/mL |
|
|
|
|
|
|
MICRO |
|
88545-9 |
|
Probe.amp.tar |
|
|
Both |
|
|
|
0 |
CMV DNA # DBS NAA+probe |
|
|
|
|
|
#; 3 Self-Sustaining Sequence Replication; 3SR SR; ABS; absolute; absolutes; Amplif; Amplification; Amplified; Blood; CMV; Cnt; Count; Count/volume; CT; Cytomegalo virus; Cytomgal; DBS; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; Dried blood spot; Filter paper; FP; HHV-5; Human Herpesvirus-5; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Number concentration; Number Concentration (count/vol); PCR; Point in time; Polymerase chain reaction; Probe amp; Probe with ampification; Probe with target amplification; QBR; QNT; Quan; Quant; Quantitative; Random; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification; Viral load; WB; Whole blood |
2.64 |
2.64 |
|
|
|
|
|
|
|
{copies}/mL |
|
|
|
0 |
88546-7 |
Chlamydophila pneumoniae DNA |
PrThr |
Asp |
Pt |
Ord |
Probe.amp.tar |
|
ACTIVE |
Chlamydophila pneumoniae DNA [Presence] in Aspirate by NAA with probe detection |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
88546-7 |
|
Probe.amp.tar |
|
|
Both |
|
|
|
0 |
C pneum DNA Aspirate Ql NAA+probe |
|
|
|
|
|
3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Aspirate; C pneum; C pneumo; C pneumoniae; Chlamydia; Chlamydia pneumoniae; CPN; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Pneu; pneum; Pneumo; Pneumon; Pneumonia; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification; Twar agent |
2.64 |
2.64 |
|
|
|
|
|
|
|
|
|
|
|
0 |